WithdrawnNCT05268497
A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression
Medication studyAges 18–65United States
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- New Haven and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 1, 2022
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05268497
- Official title
Show the full official title
Assessment of Feasibility of Using Clinician-Directed Cognitive Behavior Therapy Supplemented by a Digital Application in Conjunction With Esketamine (SPRAVATO®) in Participants With Treatment-Resistant Depression
Recruitment & locations
WithdrawnNew Haven · Chicago · Baltimore
1 more locations
- Cincinnati
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Janssen Research & Development, LLC.
Does this study involve medication?
Yes. The study involves medication, including Esketamine and Antidepressant.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
